Cargando…

Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania

BACKGROUND: Despite 20 years of ivermectin mass distribution in the Mahenge area, Tanzania, the prevalence of onchocerciasis and epilepsy has remained high in rural villages. OBJECTIVES: We investigated the efficacy of ivermectin in reducing Onchocerca volvulus microfilariae and predictors for paras...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhwana, Dan, Mmbando, Bruno P, Dusabimana, Alfred, Mhina, Athanas, Challe, Daniel P, Fodjo, Joseph N Siewe, Makunde, Williams H, Colebunders, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993262/ https://www.ncbi.nlm.nih.gov/pubmed/36910370 http://dx.doi.org/10.4314/ahs.v22i3.65

Ejemplares similares

Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study
por: Bhwana, Dan, et al.
Publicado: (2023)

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
por: Kaiser, Christoph, et al.
Publicado: (2019)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
por: Mmbando, Bruno P., et al.
Publicado: (2018)

Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor
por: Amaral, Luís-Jorge, et al.
Publicado: (2023)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

High Prevalence of Glaucoma among Patients in an Onchocerciasis Endemic Area (Mahenge, Tanzania)
por: Otiti-Sengeri, Juliet, et al.
Publicado: (2022)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo
por: Dusabimana, Alfred, et al.
Publicado: (2021)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
por: Mandro, Michel, et al.
Publicado: (2020)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
por: Mandro, Michel, et al.
Publicado: (2020)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa
por: Siewe Fodjo, J N, et al.
Publicado: (2019)

Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon
por: Ngarka, Leonard, et al.
Publicado: (2023)

Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years
por: Greter, Helena, et al.
Publicado: (2018)

The onchocerciasis hypothesis of nodding syndrome
por: Colebunders, Robert, et al.
Publicado: (2023)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
por: O’Neill, Sarah, et al.
Publicado: (2019)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
por: Boullé, Charlotte, et al.
Publicado: (2019)

Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2020)

‘Slash and clear’ vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2021)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2018)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
por: Abd-Elfarag, Gasim, et al.
Publicado: (2018)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
por: Mukendi, Deby, et al.
Publicado: (2019)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study
por: Lakwo, T. L., et al.
Publicado: (2020)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
por: Gumisiriza, Nolbert, et al.
Publicado: (2020)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2021)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rrt9fkmrkjag3nigg0e5k1qckm